Predisposition or Protection?: COVID-19 in a Patient on LVAD Support With HIV/AIDS

Kiran Mahmood; Eman R Rashed; Estefania Oliveros; Vinh Q Chau; Taylor Hermle; Samantha Jacobs; Anuradha Lala; Aditi Singhvi; Aditya Parikh; Sean P Pinney

doi:10.1016/j.jaccas.2020.05.015

Predisposition or Protection?: COVID-19 in a Patient on LVAD Support With HIV/AIDS

JACC Case Rep. 2020 Jul 15;2(9):1337-1341. doi: 10.1016/j.jaccas.2020.05.015. Epub 2020 May 19.

Authors

Affiliations

¹ Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
² Department of Cardiothoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, New York.
³ Department of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York.

Abstract

There is a desperate search to discover effective therapies against coronavirus disease-2019 (COVID-19). Patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) comprise a unique population whose clinical course may provide insights into the effects of antiretroviral therapy on COVID-19. We describe the case of a patient with HIV/AIDS on left ventricular assist device support who was hospitalized and recovered from COVID-19. (Level of Difficulty: Intermediate.).

Keywords: AIDS, acquired immunodeficiency syndrome; ART, antiretroviral therapy; COVID-19, coronavirus disease-2019; HIV, human immunodeficiency virus; HIV/AIDS; IL, interleukin; LVAD; LVAD, left ventricular assist device; SARS, severe acute respiratory syndrome; SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2; antiretroviral therapy; coronavirus disease; mechanical circulatory support.

Publication types

Case Reports